- Conditions
- Erythroleukoplakia, Leukoplakia, Verrucous Oral Leukoplakia
- Interventions
- Pembrolizumab
- Biological
- Lead sponsor
- Jonsson Comprehensive Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2027
- U.S. locations
- 3
- States / cities
- La Jolla, California • Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Jul 29, 2025 · Synced May 22, 2026, 2:46 AM EDT